Clinical Trial Update: A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia. [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluating S,S-Reboxetine in patients with fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• S,S-Reboxetine (reboxetine)

Snippet

Sponsor: Pfizer | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED